USPTO serial 98674089
TRIGEN
Reviewed by CopyMark Law Group
Status 774
- Filing date
- Status date
- Registration date
- —
- Examiner
- LOBO, DEBORAH E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with TRIGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
NEIL C. JONES
NEIL C. JONES NELSON MULLINS RILEY & SCARBOROUGH LLP301 SOUTH COLLEGE STREETSUITE 2300, IP DEPARTMENTCHARLOTTE, NC 28202Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Full line of pharmaceutical products, namely pharmaceutical products and preparations for treating diseases and conditions in gynecology and women's health, pharmaceutical products and preparations for use as prenatal supplements, pharmaceutical products and preparations for use as iron supplements, pharmaceutical products and preparations for use as multivitamin and mineral supplements, vitamin supplements and nutraceuticals for use as dietary supplements, pharmaceutical products and preparations for treating symptoms associated with menopause, pharmaceutical products and preparations for treating menopause and post menopause symptoms and conditions, pharmaceutical products and preparations for use in pain management, pharmaceutical products and preparations for use as opioid analgesics, pharmaceutical products and preparations for treating musculoskeletal conditions, and pharmaceutical products and preparations for use as a centrally-acting agents for musculoskeletal conditions; pharmaceutical preparations for managing and relieving pain and inflammation, pharmaceutical preparations for use in the treatment of musculoskeletal conditions, soft tissue conditions, and arthritis, pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, and executive functioning disorder, and pharmaceutical products and preparations for use as antidepressants | ACTIVE | Oct 25, 2013 |
| 042 | Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Pharmaceutical research and development; Pharmaceutical company services, namely, professional medical company services being pharmaceutical product research and development; Generic pharmaceutical research and development | ACTIVE | Oct 25, 2013 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 8, 2026 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Apr 8, 2026 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Apr 6, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 7, 2026 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Dec 9, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 9, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 3, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 13, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 10, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 10, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 10, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 29, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 29, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 29, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 6, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 6, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 6, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 6, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| May 6, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Feb 6, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 23, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 30, 2024 | NWAP | NEW APPLICATION ENTERED | — |